SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-21-004583
Filing Date
2021-04-22
Accepted
2021-04-22 07:00:44
Documents
5
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20210603xdef14a.htm DEF 14A 616977
2 GRAPHIC tmb-20210603xdef14a012.jpg GRAPHIC 77302
3 GRAPHIC tmb-20210603xdef14a001.jpg GRAPHIC 3705
4 GRAPHIC tmb-20210603xdef14a010.jpg GRAPHIC 4899
5 GRAPHIC tmb-20210603xdef14a011.jpg GRAPHIC 101315
  Complete submission text file 0001558370-21-004583.txt   876345
Mailing Address 640 LEE ROAD SUITE 200 WAYNE PA 19087
Business Address 640 LEE ROAD SUITE 200 WAYNE PA 19087 484-324-7933
Aclaris Therapeutics, Inc. (Filer) CIK: 0001557746 (see all company filings)

IRS No.: 460571712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37581 | Film No.: 21843231
SIC: 2834 Pharmaceutical Preparations